| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/05/2007 | WO2007076260A2 Farnesoid x receptor agonists |
| 07/05/2007 | WO2007076247A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 07/05/2007 | WO2007076245A2 Novel hydrogen sulfate salt |
| 07/05/2007 | WO2007076228A2 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders |
| 07/05/2007 | WO2007076161A2 Compounds with therapeutic activity |
| 07/05/2007 | WO2007076159A2 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
| 07/05/2007 | WO2007076140A2 Treatment methods employing histamine h3 receptor antagonists, including betahistine |
| 07/05/2007 | WO2007076125A2 Zinc compositions and their use in anti-microbial applications |
| 07/05/2007 | WO2007076112A2 Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 07/05/2007 | WO2007076104A1 Vanilloid receptor ligands and their use in treatments |
| 07/05/2007 | WO2007076086A2 Tricyclic spiro compounds useful as transforming growth factor modulators |
| 07/05/2007 | WO2007076085A2 Fused pyrimidones and thiopyrimidones, and uses thereof |
| 07/05/2007 | WO2007076055A2 Compositions and methods comprising proteinase activated receptor antagonists |
| 07/05/2007 | WO2007075963A2 Systems and methods for the delivery of corticosteroids |
| 07/05/2007 | WO2007075931A2 Reactive heterocyclic derivatives and methods for their synthesis and use |
| 07/05/2007 | WO2007075923A2 Treatment of synucleinopathies |
| 07/05/2007 | WO2007075911A2 Inhibition of glycogen synthase kinase and methods of treating autoimmune or immune inflammatory disease |
| 07/05/2007 | WO2007075896A2 Heterocyclic cytokine inhibitors |
| 07/05/2007 | WO2007075884A2 Androgen receptor modulator compounds and methods |
| 07/05/2007 | WO2007075877A2 Parenteral nutrition composition containing iron |
| 07/05/2007 | WO2007075872A2 Nitroimidazole compounds |
| 07/05/2007 | WO2007075870A2 Processes for taxane derivatives and intermediates useful therein |
| 07/05/2007 | WO2007075869A2 Bicyclic heteroaryl compounds |
| 07/05/2007 | WO2007075859A2 Systems and methods for the delivery of corticosteroids having an increased lung deposition |
| 07/05/2007 | WO2007075858A2 Novel forms of tiotropium bromide and processes for preparation thereof |
| 07/05/2007 | WO2007075852A2 Calcium channel antagonists |
| 07/05/2007 | WO2007075849A2 Treatment methods using triaryl methane compounds |
| 07/05/2007 | WO2007075847A2 Glucokinase activators |
| 07/05/2007 | WO2007075841A1 Omega 3 fatty acid formulations |
| 07/05/2007 | WO2007075839A2 Glucagon injector for emergency treatment of hypoglycemia |
| 07/05/2007 | WO2007075838A2 Pure and stable tiotropium bromide |
| 07/05/2007 | WO2007075834A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy |
| 07/05/2007 | WO2007075833A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| 07/05/2007 | WO2007075825A2 Lipophilic anticancer drug compounds |
| 07/05/2007 | WO2007075808A2 Methods for preventing and/or treating a cell proliferative disorder |
| 07/05/2007 | WO2007075801A2 Method and system for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 07/05/2007 | WO2007075800A2 Methods and systems for the delivery of corticosteroids |
| 07/05/2007 | WO2007075799A2 Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 07/05/2007 | WO2007075798A2 Methods and systems for the delivery of corticosteroids having an increased lung deposition |
| 07/05/2007 | WO2007075794A2 Oral formulations comprising tigecycline |
| 07/05/2007 | WO2007075792A1 Methods of treating gastrointestinal tract infections with tigecycline |
| 07/05/2007 | WO2007075772A2 Compounds, screens, and methods of treatment |
| 07/05/2007 | WO2007075752A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| 07/05/2007 | WO2007075751A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
| 07/05/2007 | WO2007075717A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| 07/05/2007 | WO2007075702A2 Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist |
| 07/05/2007 | WO2007075698A2 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| 07/05/2007 | WO2007075695A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder |
| 07/05/2007 | WO2007075688A2 Substituted aniline derivatives useful as histamine h3 antagonists |
| 07/05/2007 | WO2007075650A2 Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders |
| 07/05/2007 | WO2007075621A1 Control of cci-779 dosage form stability through control of drug substance impurities |
| 07/05/2007 | WO2007075605A2 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production |
| 07/05/2007 | WO2007075572A2 Orally active purine-based inhibitors of heat shock protein 90 |
| 07/05/2007 | WO2007075567A1 Triazolopyridazines as tyrosine kinase modulators |
| 07/05/2007 | WO2007075554A2 Combination of igfr inhibitor and anti-cancer agent |
| 07/05/2007 | WO2007075542A2 Nitric oxide enhancing pyruvate compounds, compositions and methods of use |
| 07/05/2007 | WO2007075541A2 Nitric oxide enhancing glutamic acid compounds, compositions and methods of use |
| 07/05/2007 | WO2007075528A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 07/05/2007 | WO2007075525A2 Combination of an iap-inhibitor and a taxane7 |
| 07/05/2007 | WO2007075524A2 Substituted piperidines as calcium channel blockers |
| 07/05/2007 | WO2007075492A1 Lipophilic anticancer drug compounds |
| 07/05/2007 | WO2007075468A1 Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods |
| 07/05/2007 | WO2007075465A1 Dimers and adducts of 6-[(substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 07/05/2007 | WO2007075452A2 Lyophilized compositions of a triazolopyrimidine compound |
| 07/05/2007 | WO2007075388A2 Methods of locally treating and preventing cardiac disorders |
| 07/05/2007 | WO2007075387A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 07/05/2007 | WO2007075377A2 Certain chemical entities, compositions and methods |
| 07/05/2007 | WO2007075269A2 Method for inhibiting tooth displacement with non-antibacterial tetracyline formulations |
| 07/05/2007 | WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | WO2007075186A2 Antimicrobial therapy for bacterial infections |
| 07/05/2007 | WO2007075177A2 Antibiotics targeting mreb |
| 07/05/2007 | WO2007075176A1 Compositions and methods of sensitizing methicillin resistant staphylococcus aureus to oxacillin |
| 07/05/2007 | WO2007075171A1 Pharmaceutical formulations of fenofibrate having improved bioavailability |
| 07/05/2007 | WO2007075151A1 Composite vasodilator based on a no-group donator and a promoter |
| 07/05/2007 | WO2007075145A1 Benzopyranone derivatives and their use as anti-coronaviral agents |
| 07/05/2007 | WO2007075142A1 Long term weight maintenance |
| 07/05/2007 | WO2007075124A1 Mix for quality control of the medicine 'glycine tablets for sublingual applying o.1g.' and its preparation method |
| 07/05/2007 | WO2007075119A1 Pharmaceutical composition for photodynamic therapy and a method for treating oncological diseases by using said composition |
| 07/05/2007 | WO2007075102A1 Medicinal agent for treating viral infections |
| 07/05/2007 | WO2007075095A1 Process for the preparation of pramipexole base and/or its salts |
| 07/05/2007 | WO2007075094A1 New derivatives of epirubicin, their medicinal application and pharmaceuticaly acceptable forms of drugs |
| 07/05/2007 | WO2007075092A1 New derivatives of epirubicin, their medicinal application and pharmaceuticals acceptable forms of drugs |
| 07/05/2007 | WO2007075077A1 Use of transcriptome-modifying agents and chemotherapy or radiotherapy against cancer |
| 07/05/2007 | WO2007075017A1 Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid |
| 07/05/2007 | WO2007075009A1 Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof |
| 07/05/2007 | WO2007074940A1 P2x4 receptor antagonist |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074915A1 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 07/05/2007 | WO2007074910A1 Controlled release solid preparation |
| 07/05/2007 | WO2007074909A1 Controlled release solid preparation |
| 07/05/2007 | WO2007074904A1 Aqueous pharmaceutical composition |
| 07/05/2007 | WO2007074884A1 Therapeutic agent for diabetes |
| 07/05/2007 | WO2007074871A1 Novel cxcr4 antagonist and use thereof |
| 07/05/2007 | WO2007074868A1 Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| 07/05/2007 | WO2007074856A1 Method of producing solid preparation disintegrating in the oral cavity |
| 07/05/2007 | WO2007074786A1 Probe for diagnosis of conformational disease |
| 07/05/2007 | WO2007074753A1 Pharmaceutical comprising substituted urea derivative |
| 07/05/2007 | WO2007074707A1 THERAPEUTIC AGENT FOR NEUROBLASTOMA TARGETING ARID3b |
| 07/05/2007 | WO2007074641A1 Pharmaceutical preparation of aqueous solution containing platinum complex |
| 07/05/2007 | WO2007074604A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance |